{"version":"1.0","provider_name":"Trade Brains Features","provider_url":"https:\/\/tradebrains.in\/features","author_name":"PTI News","author_url":"https:\/\/tradebrains.in\/features\/author\/ptinews\/","title":"Alembic Pharma gets final USFDA approval for Lacosamide tablet","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"NwEw4VmjEJ\"><a href=\"https:\/\/tradebrains.in\/features\/biz-alembic-pharma-usfda-4\/\">Alembic Pharma gets final USFDA approval for Lacosamide tablet<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/tradebrains.in\/features\/biz-alembic-pharma-usfda-4\/embed\/#?secret=NwEw4VmjEJ\" width=\"600\" height=\"338\" title=\"&#8220;Alembic Pharma gets final USFDA approval for Lacosamide tablet&#8221; &#8212; Trade Brains Features\" data-secret=\"NwEw4VmjEJ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"New Delhi, Mar 21 (PTI) Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic version of Lacosamide tablet, indicated for the treatment of partial-onset seizures in patients of 4 years of age and older. The approval by the US Food &#038; Drug Administration (USFDA) is [&hellip;]"}